BioNTech Partners With UK To Provide Up To 10,000 Patients With MRNA Cancer Immunotherapies By 2030
6/1 04:54
(RTTNews) - BioNTech SE (BNTX) said that it signed a Memorandum of Understanding with the Government of the United Kingdom to benefit patients by accelerating clinical trials for personalized mRNA immunotherapies with the aim to provide personalized cancer therapies for up to 10,...